Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05294705 · ClinicalTrials.gov registry record
The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 565
- Enrollment target
NCT05294705 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 565 participants.
The verdict
NCT05294705 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 565 participants
- Enrollment target
Study Summary
This is a multicenter longitudinal study that aims to validate a set of measures that were previously identified as promising candidate biomarkers and/or sensitive and reliable objective measures of social function in ASD for potential use in clinical trials. The confirmation study will repeat the data collection and analysis protocols from the original ABC-CT study. This confirmation study will recruit 200 ASD and 200 TD comparison participants who are 6-11 years old, matching the overall sample size but providing a larger normative reference sample and greater statistical power for group comparisons.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 565 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2025-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05294705
The ClinicalTrials.gov registry entry for NCT05294705 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 565 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05294705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05294705 about?
NCT05294705 is a clinical study titled "The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study". This is a multicenter longitudinal study that aims to validate a set of measures that were previously identified as promising candidate biomarkers and/or sensitive and reliable objective measures of social function in ASD for potential use in clinical trials. The confirmation study will repeat the d...
What is the current status of trial NCT05294705?
This trial is currently completed. The enrollment target is 565 participants. The study started on 2022-04-11. Estimated completion is 2025-08-31.
Who is sponsoring clinical trial NCT05294705?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.